시장보고서
상품코드
1088888

세계의 혈장 단백질 치료제 시장 분석(2022-2032년) : 제품별, 용도별 예측, 지역별, 주요 국가의 분석, 주요 기업, 신종 코로나바이러스 감염증(COVID-19)으로부터 회복 시나리오

Plasma Protein Therapeutics Market Report 2022-2032: Forecasts by Product, by Application, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 225 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈장 단백질 치료제 시장 규모는 2022년에는 280억 달러 이상에 달할 전망입니다. 또한 2032년까지 시장 매출이 크게 확대될 것으로 전망됩니다.

세계의 혈장 단백질 치료제(Plasma Protein Therapeutics) 시장에 대해 분석했으며, 제품 개요와 시장의 기본 구조·최신 상황, 주요 성장 촉진·억제요인, 시장 규모 추정치·예측치(2022-2032년), 제품별·용도별 및 지역별·주요 국가의 상세 동향, 주요 기업 개요, COVID-19의 영향과 회복 시나리오 등의 정보를 정리하여 전해드립니다.

목차

제1장 분석 개요

제2장 주요 요약

제3장 세계의 혈장 단백질 치료제 시장 역학

  • 혈장 단백질 치료제 시장에 대한 COVID-19의 영향
  • 혈장 단백질 치료제 시장 현재 동향
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 세계 시장의 기회
  • Porter's Five Forces 분석
  • SWOT 분석

제4장 세계의 혈장 단백질 치료제 시장 분석 : 제품별

  • 부문별 개요
  • 면역글로불린
  • 알부민
  • 응고인자
  • C1-에스테라제 억제제(C1-INH)
  • 세계의 시장 규모 추정과 예측 : 제품별
    • COVID-19 이전 시장 시나리오
    • COVID-19 이후 시장 시나리오(V자형/U자형/W자형/L자형 회복 분석)

제5장 세계의 혈장 단백질 치료제 시장 분석 : 용도별

  • 부문별 개요
  • 혈우병
  • 원발성 면역결핍증(PID)
  • 특발성 혈소판 감소성 자반증(ITP)
  • 2차 면역결핍
  • 유전성 혈관부종
  • 세계의 시장 규모 추정과 예측 : 용도별

제6장 혈장 단백질 치료제 시장 : 지역별·주요 국가의 예측(2022-2032년)

제7장 북미의 혈장 단백질 치료제 시장

  • 지역별 개요
  • 혈장 단백질 치료제 시장 예측 : 국가별(2022-2032년)
  • 혈장 단백질 치료제 시장 예측 : 제품별
  • 혈장 단백질 치료제 시장 예측 : 용도별
  • 미국
  • 캐나다
  • COVID-19 이후 회복 시나리오 : 국가별

제8장 유럽의 혈장 단백질 치료제 시장

  • 지역별 개요
  • 혈장 단백질 치료제 시장 예측 : 국가별(2022-2032년)
  • 혈장 단백질 치료제 시장 예측 : 제품별
  • 혈장 단백질 치료제 시장 예측 : 용도별
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽 국가
  • COVID-19 이후 회복 시나리오 : 국가별

제9장 아시아태평양의 혈장 단백질 치료제 시장

  • 지역별 개요
  • 혈장 단백질 치료제 시장 예측 : 국가별(2022-2032년)
  • 혈장 단백질 치료제 시장 예측 : 제품별
  • 혈장 단백질 치료제 시장 예측 : 용도별
  • 일본의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 중국의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 인도의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 호주의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 한국의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 기타 아시아태평양 국가의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • COVID-19 이후 회복 시나리오 : 국가별

제10장 라틴아메리카의 혈장 단백질 치료제 시장

  • 지역별 개요
  • 혈장 단백질 치료제 시장 예측 : 국가별(2022-2032년)
  • 혈장 단백질 치료제 시장 예측 : 제품별
  • 혈장 단백질 치료제 시장 예측 : 용도별
  • 브라질의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 멕시코의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 기타 라틴아메리카 국가의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • COVID-19 이후 회복 시나리오 : 국가별

제11장 중동 및 아프리카의 혈장 단백질 치료제 시장

  • 시장 개요
  • 혈장 단백질 치료제 시장 예측 : 국가별(2022-2032년)
  • 혈장 단백질 치료제 시장 예측 : 제품별
  • 혈장 단백질 치료제 시장 예측 : 용도별
  • 걸프협력회의(GCC) 국가의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 남아프리카공화국의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • 기타 중동 및 아프리카 국가의 혈장 단백질 치료제 시장 예측(2022-3032년)
  • COVID-19 이후 회복 시나리오 : 국가별

제12장 기업 개요

  • ADMA Biologics, Inc.
    • 기업 현황
    • 기업 개요
    • 재무 분석
    • 제품 벤치마크
    • 최근의 동향
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings Inc.
  • CSL Behring
  • Grifols SA
  • Kedrion SpA
  • Octapharma AG
  • Takeda Pharmaceutical Company Ltd

제13장 결론과 제안

KSM 22.06.28

Title:
Plasma Protein Therapeutics Market Report 2022-2032
Forecasts by Product (Immunoglobulins, Albumin, Coagulation Factors, C1-Esterase Inhibitor (C1-INH), Other), by Application (Hemophilia, Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura (ITP), Secondary Immunodeficiency, Hereditary Angioedema, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

Plasma Protein Therapeutics Market, 2022 to 2032- our new study reveals the latest industry trends, R&D progress, and predicted revenues

Increase of Blood Donations to Fuel Demand Across Low and Middle Income Countries

Due to the worldwide initiatives, a rise in voluntary, unpaid blood donations from low- and middle-income countries has been noted to fulfil the unmet need for red blood cell concentrates. In high-income nations, however, demand for red blood cells has been steadily declining, and with global economic advancements, this trend is anticipated to continue. As a result, it seems that the quantity of recovered plasma accessible for plasma fractionation is diminishing.

COVID-19 Disruption Hampering the Industry's Ability to Keep Pace with Growing Patient Pool

Plasma products are made possible by a meticulously designed, complicated system of willing donors, donation facilities, worldwide manufacturing networks, and pharmaceutical product distribution routes, which is generally reliable under normal conditions. The situation has become complicated with the outbreak of the coronavirus disease pandemic. The pandemic had a substantial influence on the well-developed and balanced system of plasma procurement beginning in early 2020, greatly impeding the industry's capacity to keep up with expanding patient demand for these life-changing medications.

Discover how to stay ahead

Our 220+ page report provides 180+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Plasma Protein Therapeutics Market. See how to exploit the opportunities.

Forecasts to 2032 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter's Five Forces, SWOT Analysis, product profiles, and commercial developments.

Discover sales predictions for the world market and sub-markets

Product

  • Immunoglobulins
  • Albumin
  • Coagulation Factors
  • C1-Esterase Inhibitor (C1-INH)
  • Other Products

Applications

  • Hemophilia
  • Primary Immunodeficiency Disorder (PID)
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Secondary Immunodeficiency
  • Hereditary Angioedema
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

By Region

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Plasma Protein Therapeutics Market will surpass US$28 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Plasma Protein Therapeutics Market report helps you:

In summary, our 220+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Plasma Protein Therapeutics Market, with forecasts for 5 segmentations of the plasma protein therapeutics market, with forecasts for product and applications sub-segments each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2032 for five regional and 20 key national markets- See forecasts for the Plasma Protein Therapeutics Market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 9 of the companies involved in the Plasma Protein Therapeutics Market. Some of the companies profiled in this report include ADMA Biologics Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols SA, Kedrion SpA, Octapharma USA Inc., and Takeda Pharmaceutical Company Ltd, among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Plasma Protein Therapeutics Market and leading companies. You will find data, trends, and predictions.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Plasma Protein Therapeutics Market
  • 1.2 Plasma Protein Therapeutics Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered by this Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 COVID-19 Impact: Recovery Scenarios
    • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

  • 2.1 Segmental Analysis, 2022
  • 2.2 Regional Analysis, 2022

3 Global Plasma Protein Therapeutics Market Dynamics

  • 3.1 COVID-19 Impact on the Plasma Protein Therapeutics Market
  • 3.2 Current Trends in the Plasma Protein Therapeutics Market
  • 3.3 Market Driving Factors
    • 3.3.1 Increase Life Expectancy
    • 3.3.2 Provides Genomic Gains and Healthcare Savings
    • 3.3.3 Rising Demand for Immunoglobulins (IG)
    • 3.3.4 Growing Investments in Innovation
  • 3.4 Market Restraining Factors
    • 3.4.1 Stringent Regulations to Hamper Market Growth
    • 3.4.2 Demand for Plasma Therapies Outpacing Supply of Plasma
    • 3.4.3 Lack of Awareness
    • 3.4.4 COVID-19 Has Expanded the Gap Between Plasma Supply and Demand
  • 3.5 Opportunities in the Global Market
    • 3.5.1 Rising Incidence of Haemophilia
    • 3.5.2 Opportunities in Emerging Economies
  • 3.6 Porter's Five Forces Analysis
    • 3.6.1 Bargaining Power of Suppliers
    • 3.6.2 Bargaining Power of Buyers
    • 3.6.3 Threat of New Entrants
    • 3.6.4 Threat of Substitutes
    • 3.6.5 Competitive Rivalry
  • 3.7 SWOT Analysis
    • 3.7.1 Strengths
    • 3.7.2 Weaknesses
    • 3.7.3 Opportunities
    • 3.7.4 Threats

4 Global Plasma Protein Therapeutics Market Analysis by Product

  • 4.1 Segment Overview
  • 4.2 Immunoglobulins
  • 4.3 Albumin
  • 4.4 Coagulation Factors
  • 4.5 C1-Esterase Inhibitor (C1-INH)
  • 4.6 Global Market Size Estimation and Forecast by Product
    • 4.6.1 Pre-COVID-19 Market Scenario
    • 4.6.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

5 Global Plasma Protein Therapeutics Market Analysis by Applications

  • 5.1 Segment Overview
  • 5.2 Hemophilia
  • 5.3 Primary Immunodeficiency Disorder (PID)
  • 5.4 Idiopathic Thrombocytopenic Purpura (ITP)
  • 5.5 Secondary Immunodeficiency
  • 5.6 Hereditary Angioedema
  • 5.7 Global Market Size Estimation and Forecast by Applications
    • 5.7.1 Pre-COVID-19 Market Scenario
    • 5.7.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

6 Regional and Leading National Plasma Protein Therapeutics Market Forecasts 2022-2032

  • 6.1 Global Plasma Protein Therapeutics Market by Region Forecast 2022-2032
  • 6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

7 North America Plasma Protein Therapeutics Market

  • 7.1 Regional Overview
  • 7.2 North America Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 7.3 North America Plasma Protein Therapeutics Market Forecast by Product
  • 7.4 North America Plasma Protein Therapeutics Market Forecast by Applications
  • 7.5 U.S.
    • 7.5.1 U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology
    • 7.5.2 U.S. Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 7.6 Canada
    • 7.6.1 Introduction
    • 7.6.2 Canada Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 7.7 Post-COVID-19 Recovery Scenarios by Country

8 Europe Plasma Protein Therapeutics Market

  • 8.1 Regional Overview
  • 8.2 Europe Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 8.3 Europe Plasma Protein Therapeutics Market Forecast by Product
  • 8.4 Europe Plasma Protein Therapeutics Market Forecast by Applications
  • 8.5 Germany
    • 8.5.1 Plasma Donors Donate More Than Whole-Blood Donors
    • 8.5.2 Germany Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.6 UK
    • 8.6.1 UK Plasma Ban Lifted
    • 8.6.2 UK Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.7 France
    • 8.7.1 Versatile Policy to Process & Manufacture Therapeutic Plasma
    • 8.7.2 France Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.8 Italy
    • 8.8.1 Market Analysis
    • 8.8.2 Italy Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.9 Spain
    • 8.9.1 Spain Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.10 Rest of Europe
    • 8.10.1 Rest of Europe Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.11 Post-COVID-19 Recovery Scenarios by Country

9 Asia Pacific Plasma Protein Therapeutics Market

  • 9.1 Regional Overview
  • 9.2 Asia Pacific Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 9.3 Asia Pacific Plasma Protein Therapeutics Market Forecast by Product
  • 9.4 Asia Pacific Plasma Protein Therapeutics Market Forecast by Applications
  • 9.5 Japan Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.5.1 Market Analysis
    • 9.5.2 Japan Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.6 China Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.6.1 Market Analysis
    • 9.6.2 China Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.7 India Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.7.1 Market Analysis
    • 9.7.2 India Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.8 Australia Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.8.1 Australia Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.9 South Korea Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.9.1 Market Analysis
    • 9.9.2 South Korea Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.10 Rest of Asia Pacific Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.10.1 Rest of Asia Pacific Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.11 Post-COVID-19 Recovery Scenarios by Country

10 Latin America Plasma Protein Therapeutics Market

  • 10.1 Regional Overview
  • 10.2 Latin America Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 10.3 Latin America Plasma Protein Therapeutics Market Forecast by Product
  • 10.4 Latin America Plasma Protein Therapeutics Market Forecast by Applications
  • 10.5 Brazil Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 10.5.1 Market Analysis
    • 10.5.2 Brazil Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 10.6 Mexico Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 10.6.1 CSL Behring and Grifols to appeal US Border Patrol's Ban on Mexican Plasma Donations
    • 10.6.2 Mexico Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 10.7 Rest of Latin America Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 10.7.1 Rest of Latin America Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 10.8 Post-COVID-19 Recovery Scenarios by Country

11 Middle East and Africa Plasma Protein Therapeutics Market

  • 11.1 Market Overview
  • 11.2 Middle East and Africa Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 11.3 Middle East and Africa Plasma Protein Therapeutics Market Forecast by Product
  • 11.4 Middle East and Africa Plasma Protein Therapeutics Market Forecast by Applications
  • 11.5 GCC Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 11.5.1 GCC Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 11.6 South Africa Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 11.6.1 South Africa Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 11.7 Rest of Middle East and Africa Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 11.7.1 Rest of Middle East and Africa Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 11.8 Post-COVID-19 Recovery Scenarios by Country

12 Company Profiles

  • 12.1 ADMA Biologics, Inc.
    • 12.1.1 Company Snapshot
    • 12.1.2 Company Overview
    • 12.1.3 Financial Analysis
    • 12.1.4 Product Benchmarking
    • 12.1.5 Recent Developments
  • 12.2 Bio Products Laboratory Ltd.
    • 12.2.1 Company Snapshot
    • 12.2.2 Company Overview
    • 12.2.3 Product Benchmarking
    • 12.2.4 Recent Developments
  • 12.3 Biotest AG
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Financial Analysis
    • 12.3.4 Product Benchmarking
    • 12.3.5 Recent Developments
  • 12.4 China Biologic Products Holdings Inc.
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Product Benchmarking
    • 12.4.4 Recent Developments
  • 12.5 CSL Behring
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Financial Analysis
    • 12.5.4 Product Benchmarking
    • 12.5.5 Recent Developments
  • 12.6 Grifols SA
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Financial Analysis
    • 12.6.4 Product Benchmarking
    • 12.6.5 Recent Developments
  • 12.7 Kedrion SpA
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Financial Analysis
    • 12.7.4 Product Benchmarking
  • 12.8 Octapharma AG
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Product Benchmarking
    • 12.8.4 Recent Developments
  • 12.9 Takeda Pharmaceutical Company Ltd
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Financial Analysis
    • 12.9.4 Product Benchmarking
    • 12.9.5 Recent Developments

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks
  • 13.2 Recommendations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제